UnitedHealth Group faces real PBM reform risks, but legal paths, financials, and market pricing suggest opportunity in ...

The entire contents of the call, including the presentation and question-and-answer ... independent national lab to be selected to the Optum Health Preferred Lab Network. The Optum Health PLN ...

The drug has been chosen as the sole ustekinumab by BCBSM, Florida Healthcare Plan, and other closed-door health systems.

Biocon Biologics has secured multiple market access agreements for Yesintek (ustekinumab-kfce), its biosimilar to Stelara (ustekinumab). The market access agreements from numerous plans represent more ...

Biocon Biologics Ltd., today announced the Company has secured multiple market access agreements for Yesintek™ (ustekinumab-kfce), its biosimilar to Stelara® (ustekinumab).

Biocon Biologics' Yesintek, a biosimilar to Stelara, has secured significant market access in the US, covering over 100 million lives. Multiple formularies, including Express Scripts, Cigna, and ...

UnitedHealth Group's pharmacy benefit manager, Optum Rx, said on Wednesday it ... after its investor day presentations were canceled last month by the murder of executive Brian Thompson outside ...

You can reach Bob on Signal at bobjherman.09. SAN DIEGO — Optum, the health data and care provider division of UnitedHealth Group, is developing a way to calculate how sick Medicare patients are ...

More Optum, one of the nation’s largest providers of medical care, the company said April 29, 2025. UnitedHealth Group Inc. headquarters stands in Minnetonka, Minnesota, U.S., on Wednesday ...

(Reuters) -UnitedHealth Group said on Tuesday insider Patrick Conway will take on the top job at Optum, its health services segment, replacing Heather Cianfrocco, who will take on a new role ...

UnitedHealth Group announced Tuesday that Patrick Conway, M.D., would take the helm of its Optum division. Conway, an insurance industry and health policy veteran, was previously the CEO of Optum ...